Both in Biotechnology
Cardiff Oncology vs Champions Oncology
Over the past year CRDF returned −61.0% and CSBR returned −28.4%; their daily moves had a correlation of 0.02.
CRDF −61.0% CSBR −28.4%Growth of $1, one year, split-adjusted
| Metric | CRDF | CSBR |
|---|---|---|
| Price | $0.8664 | $4.84 |
| Market cap | $67.4M | $67.4M |
| Today | +0.38% | +0.21% |
| 1 month | −19.0% | −3.4% |
| 6 months | −48.4% | −19.1% |
| Year to date | −69.2% | −30.0% |
| 1 year | −62.5% | — |
| Revenue growth (YoY) | −14.0% | +8.8% |
| Gross margin | 100.0% | 50.5% |
| Net margin | −8882.7% | −2.8% |
| P/E (TTM) | — | — |
| Price / sales | 132.7× | 1.1× |
| Net cash | $34.5M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 71.5% | 34.9% |
| Short % of float | 17.7% | 1.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).